![](https://aiolux-shared.s3.us-east-2.amazonaws.com/aiolux-logo-mid.png)
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
[ADAP] Adaptimmune Therapeutics plc - Short-Term Debt
Data updated 2024-Mar-23 (Saturday)Note: Detailed Statistics for Short-Term Debt in Balance Sheet for Adaptimmune Therapeutics plc [NASDAQ:ADAP] with frequency distribution chart that analyze trends & history . Short-Term Debt & current portion of Long-Term Debt are owed by Company at the end of the period. View Balance Sheet for broader context
Share
Quarterly Short-Term Debt values for Adaptimmune Therapeutics plc are rounded to enhance readability
2023-Dec | 2023-Sep | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sep | |
---|---|---|---|---|---|---|
Short-Term Debt | 5.38 M | 5.08 M | 4.75 M | 2.84 M | 2.73 M | 2.47 M |
Sequential Quarter Growth | +6.0% | +6.9% | +67.2% | +4.2% | +10.3% | -3.2% |
Quarter-on Quarter Growth | +97.4% | +105.4% | +85.8% | +3.9% | +17.6% | +9.1% |
Annual Short-Term Debt values for Adaptimmune Therapeutics plc are rounded to enhance readability
2023-Dec | 2022-Dec | 2021-Dec | 2020-Dec | 2019-Dec | 2018-Dec | |
---|---|---|---|---|---|---|
Short-Term Debt | 5.38 M | 2.73 M | 2.32 M | 2.77 M | 2.49 M | - |
Year-on-Year Growth | +97.4% | +17.6% | -16.3% | +11.2% | +Inf% | NaN% |
2-yr CAGR | +52.3% | -0.8% | -3.5% | |||
3-yr CAGR | +24.8% | +3.0% | -46.7% | |||
4-yr CAGR | +21.2% | -35.9% | ||||
5-yr CAGR | -32.4% |
Frequency distribution of quarterly Short-Term Debt values from 2015-Sep-30 grouped into buckets. Latest Short-Term Debt value is 5.38 Million as of 2023-Dec-31
Subsequent stock performance post earnings date till next announcement for Adaptimmune Therapeutics plc mapped with quarterly Short-Term Debt values reported at that time. Most recent value denoted with star
Select frequency and calculation type for Short-Term Debt above for vertical axis in scatter chart. Additionally choose type of performance for horizontal axis
Bayesian (Conditional Probability) analysis for Adaptimmune Therapeutics plc with subsequent post-earnings performance given Short-Term Debt values. Analysis uses quarterly data and subsequent absolute performance. Most recent quarter is denoted with a star and corresponding partial performance is excluded from calculations
Underperform (absolute perf.) | Outperform (absolute perf.) | |
---|---|---|
Short-Term Debt - Low | 65% | 35% |
Short-Term Debt - Medium | 47% | 53% |
Short-Term Debt - High | 41% | 59% |
Short-Term Debt (Sequential growth %) - Low | 52% | 48% |
Short-Term Debt (Sequential growth %) - Medium | 52% | 48% |
Short-Term Debt (Sequential growth %) - High | 44% | 56% |
Short-Term Debt (QoQ growth %) - Low | 59% | 41% |
Short-Term Debt (QoQ growth %) - Medium | 59% | 41% |
Short-Term Debt (QoQ growth %) - High | 35% | 65% |
Related to Adaptimmune Therapeutics plc
Information for Adaptimmune Therapeutics plc
Current Detail : Recent daily/monthly performance & benchmark comparison
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers Currently Viewing
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2024-Jun-14 on Google
SEC Reports : Quarterly reports around 2024-Jun-14 on SEC Edgar
Compare Adaptimmune Therapeutics plc with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Adaptimmune Therapeutics plc
Industry : Biotechnology industry performance which includes Adaptimmune Therapeutics plc